Opiate dependence treatment with buprenorphine: One year's experience in a family practice residency setting

Journal of Addictive Diseases

Volumn 24, Issue 2, 2005, Pages 25-32

  Colameco, Stephen ^a,b,c   Armando, John ^a   Trotz, Christopher ^a  

^a Underwood Memorial Hospital   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Life Care Medical Center   (United States)

Author keywords

Addiction treatment; Buprenorphine; Family practice; Opiate; Substance abuse

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; NALOXONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AWARENESS; CLINICAL ARTICLE; DRUG EFFICACY; GENERAL PRACTICE; HEALTH PROGRAM; HUMAN; OPIATE ADDICTION; PATIENT SELECTION; RESIDENCY EDUCATION; SUBSTANCE ABUSE; TRAINING; TREATMENT OUTCOME;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; COUNSELING; FAMILY PRACTICE; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS;

EID: 18044395325     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v24n02_03     Document Type: Article

References (15)

1. Samet H et al. Benefits of linking primary medical care and substance abuse services: patient, provider, and social perspectives. Arch Intern Med. 2001;161:85-91.
2. Laine C et al. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA. 2001;285:2355-2362.
3. Weisner C et al. Integrating primary medical care with addiction treatment, a randomized control trial. JAMA. 2001;286:1715-1723.
4. Stuart M. Opioid-dependent people may prefer receiving treatment from GP offices compared to narcotics programmes. Evidence-Based Healthcare. 2002;6(2): 56-57.
5. Resnick RB, Galanter M, Resnick E, Pycha C. Buprenorphine treatment of heroin dependence (detoxification and maintenance) in a private practice setting. J Addict Dis. 2001;20:75-83.
6. Gibson AE, Doran CM, Bell JR, Ryan A, Lintzeris N. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial. Medical Journal of Australia. 2003;179(1):38-42.
7. Mattick R et al. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction. 2003;98(4):441-52.
8. Kakko J et al. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomized, placebo-controlled trial. Lancet. 2003;361(9358):662-8.
9. Gerra G et al. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Drug & Alcohol Dependence. 2004;75(1):37-45.
10. Brooner RK. Psychiatric and substance use comorbidity among treatment-seeking opioid users. Arch Gen Psych. 1997; (54):71-80.
11. Miller NS. Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am J Drug and Alcohol Abuse. 1996; (22):95-107.
12. Miller NS. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Academic Medicine. 2001;76(5):410-8.
13. McGlynn EA. The quality of health care delivered to adults in the United States. NEJM 2003;384(26):2635-45.
14. Rockett IRH. Assessing substance abuse treatment need: a statewide hospital emergency department study. Ann Emerg Med. 2003;41:802-13.
15. Vastag B. In-office opiate treatment "not a panacea": physicians slow to embrace therapeutic option. JAMA. 2003;290(6):731-5.